$11.30
+0.0300 (+0.266%)
At Close: Jun 22, 2026
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
10:41am, Monday, 15'th Jun 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
10:40am, Friday, 29'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
10:40am, Wednesday, 13'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Fresenius SE & Co. KGaA (FSNUY) Q1 2026 Earnings Call Transcript
01:31pm, Wednesday, 06'th May 2026
Fresenius SE & Co. KGaA (FSNUY) Q1 2026 Earnings Call Transcript
Fresenius SE & Co. KGaA (FSNUY) Q4 2025 Earnings Call Transcript
07:27pm, Wednesday, 25'th Feb 2026
Fresenius SE & Co. KGaA (FSNUY) Q4 2025 Earnings Call Transcript
Fresenius SE & Co. KGaA (FSNUY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
02:26pm, Wednesday, 14'th Jan 2026
Fresenius SE & Co. KGaA (FSNUY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Fresenius SE & Co. (OTCMKTS:FSNUY) vs. U.S. Physical Therapy (NYSE:USPH) Head to Head Review
02:24am, Tuesday, 06'th Jan 2026
Fresenius SE and Co. (OTCMKTS:FSNUY - Get Free Report) and U.S. Physical Therapy (NYSE: USPH - Get Free Report) are both medical companies, but which is the superior business? We will compare the two
Fresenius SE & Co. KGaA (FSNUY) Analyst/Investor Day Transcript
12:09pm, Monday, 15'th Dec 2025
Fresenius SE & Co. KGaA (FSNUY) Analyst/Investor Day Transcript
Financial Review: Fresenius SE & Co. (OTCMKTS:FSNUY) vs. DaVita (NYSE:DVA)
02:48am, Friday, 21'st Nov 2025
Fresenius SE and Co. (OTCMKTS:FSNUY - Get Free Report) and DaVita (NYSE: DVA - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses ba
Fresenius SE & Co. KGaA (FSNUY) Q3 2025 Earnings Call Transcript
05:01pm, Wednesday, 05'th Nov 2025
Fresenius SE & Co. KGaA (OTCPK:FSNUY) Q3 2025 Earnings Call November 5, 2025 7:30 AM EST Company Participants Nick Stone - Senior VP of Investor Relations & Head of Investor Relations - Fresenius Mana
Fresenius SE & Co. KGaA (FSNUF) Q2 2025 Earnings Call Transcript
02:54pm, Friday, 08'th Aug 2025
Fresenius SE & Co. KGaA (OTCPK:FSNUF) Q2 2025 Earnings Conference Call August 6, 2025 7:30 AM ET Company Participants Michael Sen - CEO, President & Chairman of Management Board of Fresenius Managemen
Fresenius: Healthy Portfolio Add
06:16am, Saturday, 07'th Jun 2025
International stocks are essential for portfolio diversification and can provide access to more attractive valuations. Fresenius is a leading global healthcare company with a strong presence and €21
Fresenius SE & Co. KGaA (FSNUF) Q1 2025 Earnings Call Transcript
10:23pm, Wednesday, 07'th May 2025
Fresenius SE & Co. KGaA (OTCPK:FSNUF) Q1 2025 Earnings Conference Call May 7, 2025 7:30 AM ET Company Participants Nick Stone - Head of Investor Relations Michael Sen - Chairman of the Management Boar
Fresenius: Turnaround For Company, Stock Price
11:49am, Sunday, 16'th Mar 2025
Fresenius SE has shown significant improvement, with a 50% stock price increase and strong financial results, including a 50.6% rise in operating income. The company's restructuring into two segments,
Fresenius SE & Co. KGaA (FSNUF) Full Year and Q4 2024 Earnings Call Transcript
12:45pm, Wednesday, 26'th Feb 2025
Call Start: 7:30 January 1, 0000 8:50 AM ET Fresenius SE & Co. KGaA (OTCPK:FSNUF) Full Year and Q4 2024 Earnings Conference Call February 26, 2025 7:30 AM ET Company Participants Nick Stone – Head o
Sign In
Buy FSNUY